• 2025
  Thiziri Tala-Ighil, Dea Garcia-Hermoso, Frédéric Dalle, Sophie Cassaing, Juliette Guitard, Karine Boukris-Sitbon, Thomas Obadia, Olivier Lortholary, Valérie Letscher-Bru, Marie-Pierre Ledoux, Taïeb Chouaki, Anne Pauline Bellanger, Célia Rouges, Marie-Elisabeth Bougnoux, Maxime Moniot, Marc Pihet, Vincent Dubée, Frédéric Gabriel, Florent Morio, Lilia Hasseine, Christine Bonnal, Maud Gits-Muselli, Estelle Perraud-Cateau, Caroline Mahinc, Muriel Nicolas, Elisabeth Chachaty, Camille Cordier, Laurence Lachaud, Laura Courtellemont, Benoït Henry, Cécile Angebault, Gilles Gargala, Adélaïde Chesnay, Marie Liesse Pacreau, Laure Kamus, Nicole Desbois-Nogard, Magalie Demar, Loïc Epelboin, Alexandre Alanio, Eric Dannaoui, Fanny Lanternier, Laurence Millon, Mathieu Blot, Laure Vincent, Ronan Le Floch, André Paugam, Francoise Botterel, Benoît Brethon, Karen Delavigne, Aliénor Xhaard, Lucie Lelièvre, Guillaume Desoubeaux, Epidemiology and Prognostic Factors Associated With Mold-Positive Blood Cultures: 10-Year Data From a French Prospective Surveillance Program (2012–2022), Clinical Infectious Diseases, In press, pp.ciae594. ⟨10.1093/cid/ciae594⟩.
• 2024
  Lortholary O, Garcia-Hermoso D, Sturny-Leclère A, Sitbon K, Nourrisson C, Letscher-Bru V, Desbois-Nogard N, Bani-Sadr F, Bastides F, Bienvenu B, Cordier C, Coste A, Danion F, Dégot T, Delarbre D, Fekkar A, Garcie C, Garrouste C, Gits-Muselli M, Guemas E, Huguenin A, Janvier F, Kamar N, Kervinio C, Le Gal S, Lesens O, Machouart M, Persat F, Picot S, Rouze A, Ranque S, Ruch Y, Saada M, Stabler S, Alanio A, Lanternier F, Desoubeaux G, Reappraising Cladophialophora bantiana phaeohyphomycosis in France: retrospective nation-based study., Lancet Microbe 2024 Oct; (): 100907.
• 2024
  Gouzien L, Che D, Cassaing S, Lortholary O, Letscher-Bru V, Paccoud O, Obadia T, Morio F, Moniot M, Cateau E, Bougnoux ME, Chouaki T, Hasseine L, Desoubeaux G, Gautier C, Mahinc-Martin C, Huguenin A, Bonhomme J, Sitbon K, Durand J, Alanio A, Millon L, Garcia-Hermoso D, Lanternier F, Epidemiology and prognostic factors of mucormycosis in France (2012-2022): a cross-sectional study nested in a prospective surveillance programme., Lancet Reg Health Eur 2024 Oct; 45(): 101010.
• 2024
  Paccoud O, Desnos-Ollivier M, Persat F, Demar M, Boukris-Sitbon K, Bellanger AP, Bonhomme J, Bonnal C, Botterel F, Bougnoux ME, Brun S, Cassaing S, Cateau E, Chouaki T, Cornet M, Dannaoui E, Desbois-Nogard N, Durieux MF, Favennec L, Fekkar A, Gabriel F, Gangneux JP, Guitard J, Hasseine L, Huguenin A, Le Gal S, Letscher-Bru V, Mahinc C, Morio F, Nicolas M, Poirier P, Ranque S, Roosen G, Rouges C, Roux AL, Sasso M, Alanio A, Lortholary O, Lanternier F, Features of cryptococcosis among 652 HIV-seronegative individuals in France: a cross-sectional observational study (2005-2020)., Clin Microbiol Infect 2024 Mar; (): .
• 2023
  Mfinanga S, Kanyama C, Kouanfack C, Nyirenda S, Kivuyo SL, Boyer-Chammard T, Phiri S, Ngoma J, Shimwela M, Nkungu D, Fomete LN, Simbauranga R, Chawinga C, Ngakam N, Heller T, Lontsi SS, Aghakishiyeva E, Jalava K, Fuller S, Reid AM, Rajasingham R, Lawrence DS, Hosseinipour MC, Beaumont E, Bradley J, Jaffar S, Lortholary O, Harrison T, Molloy SF, Sturny-Leclère A, Loyse A, Reduction in mortality from HIV-related CNS infections in routine care in Africa (DREAMM): a before-and-after, implementation study., Lancet HIV 2023 Oct; 10(10): e663-e673.
• 2022
  Abbara S, Freeman AF, Cohen JF, Leclerc-Mercier S, Sanchez L, Schlatter J, Cisternino S, Parker R, Cowen EW, Rouzaud C, Bougnoux ME, Lanternier F, Lionakis MS, Lortholary O, Primary Invasive Cutaneous Fusariosis in Patients with STAT3 Hyper-IgE Syndrome., J Clin Immunol 2022 Dec; (): .
• 2022
  Pommier JD, Gorman C, Crabol Y, Bleakley K, Sothy H, Santy K, Tran HTT, Nguyen LV, Bunnakea E, Hlaing CS, Aye AMM, Cappelle J, Herrant M, Piola P, Rosset B, Chevalier V, Tarantola A, Channa M, Honnorat J, Pinto AL, Rattanavong S, Vongsouvath M, Mayxay M, Phangmanixay S, Phongsavath K, Tin OS, Kyaw LL, Tin HH, Linn K, Tran TMH, Pérot P, Thuy NTT, Hien N, Phan PH, Buchy P, Dussart P, Laurent D, Eloit M, Dubot-Pérès A, Lortholary O, de Lamballerie X, Newton PN, Lecuit M, Childhood encephalitis in the Greater Mekong region (the SouthEast Asia Encephalitis Project): a multicentre prospective study., Lancet Glob Health 2022 Jul; 10(7): e989-e1002.
• 2022
  Bretagne S, Sitbon K, Desnos-Ollivier M, Garcia-Hermoso D, Letscher-Bru V, Cassaing S, Millon L, Morio F, Gangneux JP, Hasseine L, Favennec L, Cateau E, Bailly E, Moniot M, Bonhomme J, Desbois-Nogard N, Chouaki T, Paugam A, Bouteille B, Pihet M, Dalle F, Eloy O, Sasso M, Demar M, Mariani-Kurkdjian P, Robert V, Lortholary O, Dromer F, Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018)., mBio 2022 Jun; 13(3): e0092022.
• 2022
  Desnos-Ollivier M, Bretagne S, Lortholary O, Dromer F, Echinocandins Susceptibility Patterns of 2,787 Yeast Isolates: Importance of the Thresholds for the Detection of FKS Mutations., Antimicrob Agents Chemother 2022 May; 66(5): e0172521.
• 2021
  Serris A, Benzakoun J, Danion F, Porcher R, Sonneville R, Wolff M, Kremer S, Letscher-Bru V, Fekkar A, Hekimian G, Pourcher V, Bougnoux ME, Poirée S, Ader F, Persat F, Cotton F, Tattevin P, Gangneux JP, Lelièvre L, Cassaing S, Bonneville F, Houze S, Bretagne S, Herbrecht R, Lortholary O, Naggara O, Lanternier F, , , Cerebral aspergillosis in the era of new antifungals: The CEREALS national cohort study Nationwide CEREbral Aspergillosis Lesional study (CEREALS)., J Infect 2021 Nov; (): .
• 2021
  Duréault A, Tcherakian C, Poiree S, Catherinot E, Danion F, Jouvion G, Bougnoux ME, Mahlaoui N, Givel C, Castelle M, Picard C, Chansdesris MO, Lortholary O, Lanternier F, , , Spectrum of Pulmonary Aspergillosis in Hyper-IgE Syndrome with Autosomal-Dominant STAT3 Deficiency., J Allergy Clin Immunol Pract ; 7(6): 1986-1995.e3.
• 2021
  Pouvaret A, Duréault A, Garcia-Hermoso D, Serris A, Cohen JF, Guery R, Lanternier F, Lortholary O, , Combined High-Dose Caspofungin and Liposomal Amphotericin B for Treatment of Azole-Resistant Cerebral Aspergillosis., Antimicrob Agents Chemother 2021 09; 65(10): e0047421.
• 2021
  Lafont Rapnouil B, Cohen JF, Bailly E, Bernard L, Garcia-Hermoso D, Lanternier F, Horodyckid C, Limousin L, Salamé E, Zemmoura I, Desoubeaux G, Lortholary O, , Morocco as a possible source for acquisition of Rhinocladiella mackenziei., PLoS Negl Trop Dis 2021 Aug; 15(8): e0009563.
• 2021
  Desnos-Ollivier M, Lortholary O, Bretagne S, Dromer F, Azole Susceptibility Profiles of More than 9,000 Clinical Yeast Isolates Belonging to 40 Common and Rare Species., Antimicrob Agents Chemother 2021 May; 65(6): .
• 2021
  Paccoud O, Bougnoux ME, Desnos-Ollivier M, Varet B, Lortholary O, Lanternier F, , Cryptococcus gattii in Patients with Lymphoid Neoplasms: An Illustration of Evolutive Host-Fungus Interactions., J Fungi (Basel) 2021 Mar; 7(3): .
• 2021
  Alanio A, Gits-Muselli M, Lanternier F, Sturny-Leclère A, Benazra M, Hamane S, Rodrigues AM, Garcia-Hermoso D, Lortholary O, Dromer F, Bretagne S, , , Evaluation of a New Histoplasma spp. Quantitative RT-PCR Assay., J Mol Diagn 2021 Mar; (): .
• 2021
  Chaussade H, Cazals X, Desoubeaux G, Jouvion G, Bougnoux ME, Lefort A, Rivoisy C, Desnos-Ollivier M, Chretien F, Chouaki T, Gruson B, Bernard L, Lortholary O, Lanternier F, , , Central nervous system candidiasis beyond neonates: Lessons from a nationwide study., Med Mycol 2021 Mar; 59(3): 266-277.
• 2021
  Paccoud O, Nervo M, Alanio A, Garcia-Hermoso D, Bougnoux ME, Mateo J, Mandonnet E, Lortholary O, Lanternier F, Adle-Biassette H, , Cerebral histoplasmosis caused by Histoplasma capsulatum var. duboisii in a patient with no known immunodeficiency., J Travel Med 2021 01; 28(1): .
• 2021
  Bretagne S, Desnos-Ollivier M, Sitbon K, Lortholary O, Che D, Dromer F, No Impact of Fluconazole to Echinocandins Replacement as First-Line Therapy on the Epidemiology of Yeast Fungemia (Hospital-Driven Active Surveillance, 2004-2017, Paris, France)., Front Med (Lausanne) 2021 ; 8(): 641965.
• 2020
  Tenforde MW, Boyer-Chammard T, Muthoga C, Tawe L, Milton T, Rulaganyang I, Lechiile K, Rukasha I, Leeme TB, Govender NP, Ngidi J, Mine M, Molloy SF, Harrison TS, Lortholary O, Jarvis JN, , Diagnostic accuracy of the Biosynex CryptoPS cryptococcal antigen semi-quantitative lateral flow assay in patients with advanced HIV disease., J Clin Microbiol 2020 Oct; (): .
• 2020
  Temfack E, Rim JJB, Spijker R, Loyse A, Chiller T, Pappas PG, Perfect J, Sorell TC, Harrison TS, Cohen JF, Lortholary O, , Cryptococcal antigen in serum and cerebrospinal fluid for detecting cryptococcal meningitis in adults living with HIV: systematic review and meta-analysis of diagnostic test accuracy studies., Clin Infect Dis 2020 Aug; (): .
• 2020
  Alufandika M, Lawrence DS, Boyer-Chammard T, Kanyama C, Ndhlovu CE, Mosepele M, Tugume L, Meya D, Boulware DR, Rhein J, Muzoora C, Youssouf N, Molloy SF, Schutz C, Lortholary O, Meintjes G, Mwandumba HC, Harrison TS, Jarvis JN, , , A pragmatic approach to managing antiretroviral therapy-experienced patients diagnosed with HIV-associated cryptococcal meningitis: impact of antiretroviral therapy adherence and duration., AIDS 2020 Jul; 34(9): 1425-1428.
• 2019
  Desnos-Ollivier M, Bretagne S, Boullié A, Gautier C, Dromer F, Lortholary O, , , Isavuconazole MIC distribution of 29 yeast species responsible for invasive infections (2015-2017)., Clin Microbiol Infect 2019 May; 25(5): 634.e1-634.e4.
• 2019
  Danion F, Rouzaud C, Duréault A, Poirée S, Bougnoux ME, Alanio A, Lanternier F, Lortholary O, , Why are so many cases of invasive aspergillosis missed?, Med. Mycol. 2019 Apr; 57(Supplement_2): S94-S103.
• 2019
  Shiri T, Loyse A, Mwenge L, Chen T, Lakhi S, Chanda D, Mwaba P, Molloy SF, Heyderman R, Kanyama C, Hosseinipour MC, Kouanfack C, Temfack E, Mfinanga S, Kivuyo S, Chan AK, Jarvis JN, Lortholary O, Jaffar S, Niessen LW, Harrison TS, Addition of flucytosine to fluconazole for the treatment of cryptococcal meningitis in Africa: a multi-country cost-effectiveness analysis, Clin. Infect. Dis. 2019 Feb;.
• 2019
  Pouvaret A, Guery R, Montillet M, Molina TJ, Duréault A, Bougnoux ME, Galliot R, Lanternier F, Delarue R, Lortholary O, Concurrent cerebral aspergillosis and abdominal mucormycosis during ibrutinib therapy for chronic lymphocytic leukaemia, Clin. Microbiol. Infect. 2019 06;25(6):771-773.
• 2019
  Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN, , Correction to: AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial., Trials 2019 01; 20(1): 48.
• 2018
  Parize P, Mamez AC, Garcia-Hermoso D, Dumaine V, Poirée S, Kauffmann-Lacroix C, Jullien V, Lortholary O, Lanternier F, Successful Treatment of sp. Osteomyelitis by Conservative Surgery and Intradiaphyseal Incorporation of Amphotericin B Cement Beads, Antimicrob. Agents Chemother. 2019 Jan;63(1).
• 2018
  Dellière S, Guery R, Candon S, Rammaert B, Aguilar C, Lanternier F, Chatenoud L, Lortholary O, Understanding Pathogenesis and Care Challenges of Immune Reconstitution Inflammatory Syndrome in Fungal Infections, J Fungi (Basel) 2018 Dec;4(4).
• 2018
  Brunet K, Alanio A, Lortholary O, Rammaert B, , Reactivation of dormant/latent fungal infection., J. Infect. 2018 12; 77(6): 463-468.
• 2018
  Lawrence DS, Youssouf N, Molloy SF, Alanio A, Alufandika M, Boulware DR, Boyer-Chammard T, Chen T, Dromer F, Hlupeni A, Hope W, Hosseinipour MC, Kanyama C, Lortholary O, Loyse A, Meya DB, Mosepele M, Muzoora C, Mwandumba HC, Ndhlovu CE, Niessen L, Schutz C, Stott KE, Wang D, Lalloo DG, Meintjes G, Jaffar S, Harrison TS, Jarvis JN, , AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial., Trials 2018 Nov; 19(1): 649.
• 2018
  Loyse A, Burry J, Cohn J, Ford N, Chiller T, Ribeiro I, Koulla-Shiro S, Mghamba J, Ramadhani A, Nyirenda R, Aliyu SH, Wilson D, Le T, Oladele R, Lesikari S, Muzoora C, Kalata N, Temfack E, Mapoure Y, Sini V, Chanda D, Shimwela M, Lakhi S, Ngoma J, Gondwe-Chunda L, Perfect C, Shroufi A, Andrieux-Meyer I, Chan A, Schutz C, Hosseinipour M, Van der Horst C, Klausner JD, Boulware DR, Heyderman R, Lalloo D, Day J, Jarvis JN, Rodrigues M, Jaffar S, Denning D, Migone C, Doherty M, Lortholary O, Dromer F, Stack M, Molloy SF, Bicanic T, van Oosterhout J, Mwaba P, Kanyama C, Kouanfack C, Mfinanga S, Govender N, Harrison TS, Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries, Lancet Infect Dis 2019 Apr;19(4):e143-e147.
• 2018
  Robin C, Cordonnier C, Sitbon K, Raus N, Lortholary O, Maury S, Peffault de la Tour R, Bretagne S, Bastuji-Garin S, , Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire, Biol. Blood Marrow Transplant. 2019 Feb;25(2):354-361.
• 2018
  Danion F, Jullien V, Rouzaud C, Abdel Fattah M, Lapusan S, Guéry R, Bigé N, Morgand M, Pallet N, Lanternier F, Lortholary O, Is It Time for Systematic Voriconazole Pharmacogenomic Investigation for Central Nervous System Aspergillosis?, Antimicrob. Agents Chemother. 2018 09;62(9).
• 2018
  Temfack E, Bigna JJ, Luma HN, Spijker R, Meintjes G, Jarvis JN, Dromer F, Harrison T, Cohen JF, Lortholary O, Impact of Routine Cryptococcal Antigen Screening and Targeted Preemptive Fluconazole Therapy in Antiretroviral-naive Human Immunodeficiency Virus-infected Adults With CD4 Cell Counts <100/μL: A Systematic Review and Meta-analysis, Clin. Infect. Dis. 2019 Feb;68(4):688-698.
• 2018
  Pilmis B, Garcia-Hermoso D, Alanio A, Catherinot E, Scemla A, Jullien V, Bretagne S, Lortholary O, , Failure of voriconazole therapy due to acquired azole resistance in Aspergillus fumigatus in a kidney transplant recipient with chronic necrotizing aspergillosis., Am. J. Transplant. 2018 09; 18(9): 2352-2355.
• 2018
  Rouzaud C, Rodriguez-Nava V, Catherinot E, Méchaï F, Bergeron E, Farfour E, Scemla A, Poirée S, Delavaud C, Mathieu D, Durupt S, Larosa F, Lengelé JP, Christophe JL, Suarez F, Lortholary O, Lebeaux D, Clinical Assessment of a Nocardia PCR-Based Assay for Diagnosis of Nocardiosis, J. Clin. Microbiol. 2018 06;56(6).
• 2018
  Chammard TB, Temfack E, Lortholary O, Alanio A, , Diagnostic and therapeutic strategies in cryptococcosis: impact on outcome., Mem. Inst. Oswaldo Cruz 2018 ; 113(7): e180050.
• 2018
  Pasquier E, Kunda J, De Beaudrap P, Loyse A, Temfack E, Molloy SF, Harrison TS, Lortholary O, Long-term Mortality and Disability in Cryptococcal Meningitis: A Systematic Literature Review, Clin. Infect. Dis. 2018 Mar;66(7):1122-1132.
• 2018
  Molloy SF, Kanyama C, Heyderman RS, Loyse A, Kouanfack C, Chanda D, Mfinanga S, Temfack E, Lakhi S, Lesikari S, Chan AK, Stone N, Kalata N, Karunaharan N, Gaskell K, Peirse M, Ellis J, Chawinga C, Lontsi S, Ndong JG, Bright P, Lupiya D, Chen T, Bradley J, Adams J, van der Horst C, van Oosterhout JJ, Sini V, Mapoure YN, Mwaba P, Bicanic T, Lalloo DG, Wang D, Hosseinipour MC, Lortholary O, Jaffar S, Harrison TS, , Antifungal Combinations for Treatment of Cryptococcal Meningitis in Africa, N. Engl. J. Med. 2018 03;378(11):1004-1017.
• 2018
  Temfack E, Kouanfack C, Mossiang L, Loyse A, Fonkoua MC, Molloy SF, Koulla-Shiro S, Delaporte E, Dromer F, Harrison T, Lortholary O, Cryptococcal Antigen Screening in Asymptomatic HIV-Infected Antiretroviral Naïve Patients in Cameroon and Evaluation of the New Semi-Quantitative Biosynex CryptoPS Test, Front Microbiol 2018;9:409.
• 2018
  Rivoisy C, Vena A, Schaeffer L, Charlier C, Fontanet A, Delahaye F, Bouza E, Lortholary O, Munoz P, Lefort A, , Prosthetic Valve Candida spp. Endocarditis: New Insights Into Long-term Prognosis-The ESCAPE Study, Clin. Infect. Dis. 2018 Mar;66(6):825-832.
• 2018
  Rouzaud C, Chosidow O, Brocard A, Fraitag S, Scemla A, Anglicheau D, Bouaziz JD, Dupin N, Bougnoux ME, Hay R, Lortholary O, Lanternier F, , Severe dermatophytosis in solid organ transplant recipients: A French retrospective series and literature review, Transpl Infect Dis 2018 Feb;20(1).
• 2018
  Pilmis B, Alanio A, Lortholary O, Lanternier F, , Recent advances in the understanding and management of mucormycosis., F1000Res 2018 ; 7(): .
• 2017
  Quaesaet L, Stindel E, Lanternier F, Williams T, Jaffuel S, Moalic E, Garcia Hermoso D, Lortholary O, Ansart S, Miltefosine-based regimen as salvage therapy in Lomentospora prolificans bone and joint infection, Med Mal Infect 2018 02;48(1):63-65.
• 2017
  Guet-Revillet H, Jais JP, Ungeheuer MN, Coignard-Biehler H, Duchatelet S, Delage M, Lam T, Hovnanian A, Lortholary O, Nassif X, Nassif A, Join-Lambert O, The Microbiological Landscape of Anaerobic Infections in Hidradenitis Suppurativa: A Prospective Metagenomic Study, Clin. Infect. Dis. 2017 Jul;65(2):282-291.
• 2017
  Molloy SF, Chiller T, Greene GS, Burry J, Govender NP, Kanyama C, Mfinanga S, Lesikari S, Mapoure YN, Kouanfack C, Sini V, Temfack E, Boulware DR, Dromer F, Denning DW, Day J, Stone NRH, Bicanic T, Jarvis JN, Lortholary O, Harrison TS, Jaffar S, Loyse A, Cryptococcal meningitis: A neglected NTD?, PLoS Negl Trop Dis 2017 Jun;11(6):e0005575.
• 2017
  Bretagne S, Renaudat C, Desnos-Ollivier M, Sitbon K, Lortholary O, Dromer F, , , Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14)., J Antimicrob Chemother 2017 Jun; 72(6): 1784-1793.
• 2017
  Lortholary O, Renaudat C, Sitbon K, Desnos-Ollivier M, Bretagne S, Dromer F, , , The risk and clinical outcome of candidemia depending on underlying malignancy., Intensive Care Med 2017 May; 43(5): 652-662.
• 2017
  Guet-Revillet H, Jais JP, Ungeheuer MN, Coignard-Biehler H, Duchatelet S, Delage M, Lam T, Hovnanian A, Lortholary O, Nassif X, Nassif A, Join-Lambert O, The microbiological landscape of anaerobic infections in Hidradenitis Suppurativa: a prospective metagenomic study., Clin Infect Dis 2017 Apr 1. doi: 10.1093/cid/cix285..
• 2016
  Guégan S, Garcia-Hermoso D, Sitbon K, Ahmed S, Moguelet P, Dromer F, Lortholary O,, Ten-Year Experience of Cutaneous and/or Subcutaneous Infections Due to Coelomycetes in France, Open Forum Infect Dis 2016 Apr;3(2):ofw106.
• 2016
  Angebault C, Lanternier F, Dalle F, Schrimpf C, Roupie AL, Dupuis A, Agathine A, Scemla A, Paubelle E, Caillot D, Neven B, Frange P, Suarez F, d'Enfert C, Lortholary O, Bougnoux ME, Prospective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases, Open Forum Infect Dis 2016 Sep;3(3):ofw128.
• 2016
  Pilmis B, Puel A, Lortholary O, Lanternier F, New clinical phenotypes of fungal infections in special hosts, Clin. Microbiol. Infect. 2016 Aug;22(8):681-7.
• 2016
  Guégan S, Lanternier F, Rouzaud C, Dupin N, Lortholary O, Fungal skin and soft tissue infections, Curr. Opin. Infect. Dis. 2016 Apr;29(2):124-30.
• 2016
  Alves de Medeiros AK, Lodewick E, Bogaert DJ, Haerynck F, Van Daele S, Lambrecht B, Bosma S, Vanderdonckt L, Lortholary O, Migaud M, Casanova JL, Puel A, Lanternier F, Lambert J, Brochez L, Dullaers M, Chronic and Invasive Fungal Infections in a Family with CARD9 Deficiency, J. Clin. Immunol. 2016 Apr;36(3):204-9.
• 2016
  Morizot G, Jouffroy R, Faye A, Chabert P, Belhouari K, Calin R, Charlier C, Miailhes P, Siriez JY, Mouri O, Yera H, Gilquin J, Tubiana R, Lanternier F, Mamzer MF, Legendre C, Peyramond D, Caumes E, Lortholary O, Buffet P, Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B, PLoS Negl Trop Dis 2016 Jan;10(1):e0004304.
• 2015
  Lanternier F, Poiree S, Elie C, Garcia-Hermoso D, Bakouboula P, Sitbon K, Herbrecht R, Wolff M, Ribaud P, Lortholary O,, Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis, J. Antimicrob. Chemother. 2015 Nov;70(11):3116-23.
• 2015
  Bernardeschi C, Foulet F, Ingen-Housz-Oro S, Ortonne N, Sitbon K, Quereux G, Lortholary O, Chosidow O, Bretagne S,, Cutaneous Invasive Aspergillosis: Retrospective Multicenter Study of the French Invasive-Aspergillosis Registry and Literature Review, Medicine (Baltimore) 2015 Jul;94(26):e1018.
• 2015
  Join-Lambert O, Fraitag S, Ribadeau-Dumas F, Leguern AS, Behillil S, Del Castillo FJ, Consigny PH, Auquier F, Eb F, Sevestre H, Lortholary O, Nassif X, Nassif A, Is granulomatous mastitis a localized form of hidradenitis suppurativa?, Eur J Dermatol 2009 Jun 15..
• 2015
  Desnos-Ollivier M, Patel S, Raoux-Barbot D, Heitman J, Dromer F, , , Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation., mBio 2015 Jun; 6(3): e00311.
• 2015
  Lanternier F, Mahdaviani SA, Barbati E, Chaussade H, Koumar Y, Levy R, Denis B, Brunel AS, Martin S, Loop M, Peeters J, de Selys A, Vanclaire J, Vermylen C, Nassogne MC, Chatzis O, Liu L, Migaud M, Pedergnana V, Desoubeaux G, Jouvion G, Chretien F, Darazam IA, Schäffer AA, Netea MG, De Bruycker JJ, Bernard L, Reynes J, Amazrine N, Abel L, Van der Linden D, Harrison T, Picard C, Lortholary O, Mansouri D, Casanova JL, Puel A, Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both, J. Allergy Clin. Immunol. 2015 Jun;135(6):1558-68.e2.
• 2015
  Lelievre L, Garcia-Hermoso D, Abdoul H, Hivelin M, Chouaki T, Toubas D, Mamez AC, Lantieri L, Lortholary O, Lanternier F,, Posttraumatic mucormycosis: a nationwide study in France and review of the literature, Medicine (Baltimore) 2014 Nov;93(24):395-404.
• 2015
  Walsh TJ, Skiada A, Cornely OA, Roilides E, Ibrahim A, Zaoutis T, Groll A, Lortholary O, Kontoyiannis DP, Petrikkos G, Development of new strategies for early diagnosis of mucormycosis from bench to bedside, Mycoses 2014 Dec;57 Suppl 3:2-7.
• 2015
  Jamilloux I, Valeyre D, Lortholary O, Bernard C, Kerever S, Lelievre L, Neel A, Broussolle C, Seve P, The spectrum of opportunistic diseases complicating sarcoidosis, Autoimmun Rev 2015 Jan;14(1):64-74.
• 2014
  Lelievre L, Borderie V, Garcia-Hermoso D, Brignier AC, Sterkers M, Chaumeil C, Lortholary O, Lanternier F, Imported pythium insidiosum keratitis after a swim in Thailand by a contact lens-wearing traveler, Am. J. Trop. Med. Hyg. 2015 Feb;92(2):270-3.
• 2014
  Guet-Revillet H, Coignard-Biehler H, Jais JP, Quesne G, Frapy E, Poirée S, Le Guern AS, Le Flèche-Matéos A, Hovnanian A, Consigny PH, Lortholary O, Nassif X, Nassif A, Join-Lambert O, Bacterial pathogens associated with hidradenitis suppurativa, France., Emerg Infect Dis 2014 Dec; 20(12): 1990-8.
• 2014
  Crabol Y, Lortholary O, Invasive mold infections in solid organ transplant recipients, Scientifica (Cairo) 2014;2014:821969.
• 2014
  Richaud C, Chandesris MO, Lanternier F, Benzaquen-Forner H, Garcia-Hermoso D, Picard C, Catherinot E, Bougnoux ME, Lortholary O, Imported African histoplasmosis in an immunocompetent patient 40 years after staying in a disease-endemic area, Am. J. Trop. Med. Hyg. 2014 Nov;91(5):1011-4.
• 2014
  Lebeaux D, Ghigo JM, Lortholary O, [Infections related to implanted medical devices: the down-side of medical progress], Rev Prat 2014 May;64(5):617-9.
• 2014
  Surgers L, Bleibtreu A, Burdet C, Clermont O, Laouénan C, Lefort A, Mentré F, Carbonne B, Bingen E, Meynard JL, Denamur E,, Escherichia coli bacteraemia in pregnant women is life-threatening for foetuses, Clin. Microbiol. Infect. 2014 Dec;20(12):O1035-41.
• 2014
  Tattevin P, Revest M, Lefort A, Michelet C, Lortholary O, Fungal endocarditis: current challenges, Int. J. Antimicrob. Agents 2014 Oct;44(4):290-4.
• 2014
  Lanternier F, Barbati E, Meinzer U, Liu L, Pedergnana V, Migaud M, Héritier S, Chomton M, Frémond ML, Gonzales E, Galeotti C, Romana S, Jacquemin E, Angoulvant A, Bidault V, Canioni D, Lachenaud J, Mansouri D, Mahdaviani SA, Adimi P, Mansouri N, Jamshidi M, Bougnoux ME, Abel L, Lortholary O, Blanche S, Casanova JL, Picard C, Puel A, Inherited CARD9 deficiency in 2 unrelated patients with invasive Exophiala infection, J. Infect. Dis. 2015 Apr;211(8):1241-50.
• 2014
  Bitar D, Lortholary O, Le Strat Y, Nicolau J, Coignard B, Tattevin P, Che D, Dromer F, Population-based analysis of invasive fungal infections, France, 2001-2010, Emerging Infect. Dis. 2014 Jul;20(7):1149-55.
• 2014
  Phin N, Parry-Ford F, Harrison T, Stagg HR, Zhang N, Kumar K, Lortholary O, Zumla A, Abubakar I, Epidemiology and clinical management of Legionnaires’ disease, Lancet Infect Dis 2014 Oct;14(10):1011-21.
• 2014
  Rammaert B, Gamaletsou MN, Zeller V, Elie C, Prinapori R, Taj-Aldeen SJ, Roilides E, Kontoyiannis DP, Brause B, Sipsas NV, Walsh TJ, Lortholary O, Dimorphic fungal osteoarticular infections, Eur. J. Clin. Microbiol. Infect. Dis. 2014 Dec;33(12):2131-40.
• 2014
  Paugam A, Ancelle T, Lortholary O, Bretagne S, , Longer incubation times for yeast fungemia: importance for presumptive treatment, Diagn. Microbiol. Infect. Dis. 2014 Oct;80(2):119-21.
• 2014
  Yang ZT, Wu L, Liu XY, Zhou M, Li J, Wu JY, Cai Y, Mao EQ, Chen EZ, Lortholary O, Epidemiology, species distribution and outcome of nosocomial Candida spp. bloodstream infection in Shanghai, BMC Infect. Dis. 2014;14:241.
• 2014
  Lebeaux D, Morelon E, Suarez F, Lanternier F, Scemla A, Frange P, Mainardi JL, Lecuit M, Lortholary O, , Nocardiosis in transplant recipients., Eur J Clin Microbiol Infect Dis 2014 May; 33(5): 689-702.
• 2014
  Denis B, Guiguet M, de Castro N, Mechaï F, Revest M, Mahamat A, Gregoire GM, Lortholary O, Costagliola D, Critical importance of long-term adherence to care in HIV infected patients in the cART era: new insights from Pneumocystis jirovecii pneumonia cases over 2004-2011 in the FHDH-ANRS CO4 cohort, PLoS ONE 2014;9(4):e94183.
• 2014
  Pilmis B, Parize P, Zahar JR, Lortholary O, Alternatives to carbapenems for infections caused by ESBL-producing Enterobacteriaceae, Eur. J. Clin. Microbiol. Infect. Dis. 2014 Aug;33(8):1263-5.
• 2014
  Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira M, Munoz P, Johnson E, Meletiadis J, Pana ZD, Lackner M, Verweij P, Freiberger T, Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Guinea J, Guarro J, de Hoog S, Hope W, Kathuria S, Lortholary O, Meis JF, Ullmann AJ, Petrikkos G, Lass-Flörl C, ,, ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others, Clin. Microbiol. Infect. 2014 Apr;20 Suppl 3:27-46.
• 2014
  Chowdhary A, Meis JF, Guarro J, de Hoog GS, Kathuria S, Arendrup MC, Arikan-Akdagli S, Akova M, Boekhout T, Caira M, Guinea J, Chakrabarti A, Dannaoui E, van Diepeningen A, Freiberger T, Groll AH, Hope WW, Johnson E, Lackner M, Lagrou K, Lanternier F, Lass-Flörl C, Lortholary O, Meletiadis J, Muñoz P, Pagano L, Petrikkos G, Richardson MD, Roilides E, Skiada A, Tortorano AM, Ullmann AJ, Verweij PE, Cornely OA, Cuenca-Estrella M, , , ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi, Clin. Microbiol. Infect. 2014 Apr;20 Suppl 3:47-75.
• 2014
  Cornely OA, Arikan-Akdagli S, Dannaoui E, Groll AH, Lagrou K, Chakrabarti A, Lanternier F, Pagano L, Skiada A, Akova M, Arendrup MC, Boekhout T, Chowdhary A, Cuenca-Estrella M, Freiberger T, Guinea J, Guarro J, de Hoog S, Hope W, Johnson E, Kathuria S, Lackner M, Lass-Flörl C, Lortholary O, Meis JF, Meletiadis J, Muñoz P, Richardson M, Roilides E, Tortorano AM, Ullmann AJ, van Diepeningen A, Verweij P, Petrikkos G, , , ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013, Clin. Microbiol. Infect. 2014 Apr;20 Suppl 3:5-26.
• 2014
  Arendrup MC, Boekhout T, Akova M, Meis JF, Cornely OA, Lortholary O, , , ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections, Clin. Microbiol. Infect. 2014 Apr;20 Suppl 3:76-98.
• 2014
  Roubaud Baudron C, Panhard X, Clermont O, Mentré F, Fantin B, Denamur E, Lefort A,, Escherichia coli bacteraemia in adults: age-related differences in clinical and bacteriological characteristics, and outcome, Epidemiol. Infect. 2014 Dec;142(12):2672-83.
• 2014
  Parize P, Billaud S, Bienvenu AL, Bourdy S, le Pogam MA, Reix P, Picot S, Robert R, Lortholary O, Bouchara JP, Durieu I, Impact of Scedosporium apiospermum complex seroprevalence in patients with cystic fibrosis, J. Cyst. Fibros. 2014 Dec;13(6):667-73.
• 2014
  Bonnet C, Garcia-Hermoso D, Bertandeau E, Lortholary O, Kervinio C, Bonnan M, [Cladophialophora bantiana brain abscess: a case with long survival in metropolitan France], Rev. Neurol. (Paris) 2014 Feb;170(2):146-8.
• 2014
  Tarantola A, Goutard F, Newton P, de Lamballerie X, Lortholary O, Cappelle J, Buchy P, Estimating the burden of Japanese encephalitis virus and other encephalitides in countries of the mekong region, PLoS Negl Trop Dis 2014;8(1):e2533.
• 2014
  Join-Lambert O, Ribadeau-Dumas F, Jullien V, Kitzis MD, Jais JP, Coignard-Biehler H, Guet-Revillet H, Consigny PH, Delage M, Nassif X, Lortholary O, Nassif A., A. Dramatic reduction of clindamycin plasma concentration in hidradenitis suppurativa patients treated with the rifampin-clindamycin combination., Eur J Dermatol. 2014 Jan, 24(1) :94-5.
• 2014
  Arendrup MC, Cuenca-Estrella M, Lass-Flörl C, Hope WW, , EUCAST technical note on Candida and micafungin, anidulafungin and fluconazole, Mycoses 2014 Jun;57(6):377-9.
• 2013
  Gamaletsou MN, Rammaert B, Bueno MA, Moriyama B, Sipsas NV, Kontoyiannis DP, Roilides E, Zeller V, Prinapori R, Taj-Aldeen SJ, Brause B, Lortholary O, Walsh TJ, Aspergillus osteomyelitis: epidemiology, clinical manifestations, management, and outcome, J. Infect. 2014 May;68(5):478-93.
• 2013
  Lanternier F, Cypowyj S, Picard C, Bustamante J, Lortholary O, Casanova JL, Puel A, Primary immunodeficiencies underlying fungal infections, Curr. Opin. Pediatr. 2013 Dec;25(6):736-47.
• 2013
  Nacher M, Adenis A, Mc Donald S, Do Socorro Mendonca Gomes M, Singh S, Lopes Lima I, Malcher Leite R, Hermelijn S, Wongsokarijo M, Van Eer M, Marques Da Silva S, Mesquita Da Costa M, Silva M, Calvacante M, do Menino Jesus Silva Leitao T, Gómez BL, Restrepo A, Tobon A, Canteros CE, Aznar C, Blanchet D, Vantilcke V, Vautrin C, Boukhari R, Chiller T, Scheel C, Ahlquist A, Roy M, Lortholary O, Carme B, Couppié P, Vreden S, Disseminated histoplasmosis in HIV-infected patients in South America: a neglected killer continues on its rampage, PLoS Negl Trop Dis 2013 Nov;7(11):e2319.
• 2013
  Vironneau P, Kania R, Morizot G, Elie C, Garcia-Hermoso D, Herman P, Lortholary O, Lanternier F,, Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival, Clin. Microbiol. Infect. 2014 May;20(5):O336-9.
• 2013
  Pilmis B, Coignard-Biehler H, Jullien V, Hermine O, Touraine P, Lecuit M, Lortholary O, , Iatrogenic Cushing’s syndrome induced by posaconazole., Antimicrob Agents Chemother 2013 Nov; 57(11): 5727-8.
• 2013
  Bernard S, Mailles A, Stahl JP, , , Epidemiology of infectious encephalitis, differences between a prospective study and hospital discharge data., Epidemiol Infect 2013 Nov; 141(11): 2256-68.
• 2013
  Parize P, Angebault C, de Fonbrune FS, Suarez F, Lecuit M, Lortholary O, Bougnoux ME, , Naturotherapy as a potential source of mould infections in patients with haematological malignancies., J Hosp Infect 2013 Oct; 85(2): 163-4.
• 2013
  Irtan S, Lamerain M, Lesage F, Verkarre V, Bougnoux ME, Lanternier F, Zahar JR, Salvi N, Talbotec C, Lortholary O, Lacaille F, Chardot C, Mucormycosis as a rare cause of severe gastrointestinal bleeding after multivisceral transplantation, Transpl Infect Dis 2013 Dec;15(6):E235-8.
• 2013
  Lanternier F, Tubach F, Ravaud P, Salmon D, Dellamonica P, Bretagne S, Couret M, Bouvard B, Debandt M, Gueit I, Gendre JP, Leone J, Nicolas N, Che D, Mariette X, Lortholary O, , Incidence and risk factors of Legionella pneumophila pneumonia during anti-tumor necrosis factor therapy: a prospective French study, Chest 2013 Sep;144(3):990-8.
• 2013
  Loulergue P, Tubach F, Salmon D, Dellamonica P, Taillan B, Thorel JB, Marteau P, Bressot C, Ravaud P, Mariette X, Lortholary O, , Bacteremia in patients receiving TNF-alpha antagonists–a prospective multicenter study, J. Infect. 2013 Dec;67(6):524-8.
• 2013
  Clermont O, Glodt J, Burdet C, Pognard D, Lefort A, Branger C, Denamur E, , Complexity of Escherichia coli bacteremia pathophysiology evidenced by comparison of isolates from blood and portal of entry within single patients, Int. J. Med. Microbiol. 2013 Dec;303(8):529-32.
• 2013
  Loyse A, Dromer F, Day J, Lortholary O, Harrison TS, Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal, J. Antimicrob. Chemother. 2013 Nov;68(11):2435-44.
• 2013
  Yang ZT, Zahar JR, Méchaï F, Postaire M, Blanot S, Balfagon-Viel S, Nassif X, Lortholary O, Current ciprofloxacin usage in children hospitalized in a referral hospital in Paris, BMC Infect. Dis. 2013;13:245.
• 2013
  Denis B, Lortholary O, [Pulmonary fungal infection in patients with AIDS], Rev Mal Respir 2013 Oct;30(8):682-95.
• 2013
  Lortholary O, [Mucorales and mucormycosis], Med Sci (Paris) 2013 Mar;29 Spec No 1:3-4.
• 2013
  Lortholary O, Charlier C, Lebeaux D, Lecuit M, Consigny PH, , Fungal infections in immunocompromised travelers., Clin Infect Dis 2013 Mar; 56(6): 861-9.
• 2013
  Shoai Tehrani M, Sicre de Fontbrune F, Roth P, Allisy C, Bougnoux ME, Hermine O, Lecuit M, Lortholary O, Charlier C, , Case report of exposure to voriconazole in the second and third trimesters of pregnancy., Antimicrob Agents Chemother 2013 Feb; 57(2): 1094-5.
• 2013
  Paugam A, Lebuisson A, Lortholary O, Baixench MT, Lanternier F, Peripheral blood and bone marrow cells cultivated in Novy-Mcneal-Nicolle medium for visceral leishmaniosis diagnosis revealed Rhodotorula fungemia in an AIDS patient with lymphoma, Clin. Lab. 2013;59(1-2):215-6.
• 2013
  Mechaï F, Veziris N, Aoun O, Bille E, Lecuit M, Brossier F, Viard JP, Lortholary O, , In vivo selection of a multidrug-resistant Mycobacterium avium isolate in a patient with AIDS., Int J Tuberc Lung Dis 2013 Jan; 17(1): 141-2.
• 2012
  Lortholary O, Petrikkos G, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, Cornely OA, Cuenca-Estrella M, Donnelly JP, Garbino J, Groll AH, Herbrecht R, Hope WW, Jensen HE, Kullberg BJ, Lass-Flörl C, Meersseman W, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ, , ESCMID* guideline for the diagnosis and management of Candida diseases 2012: patients with HIV infection or AIDS, Clin. Microbiol. Infect. 2012 Dec;18 Suppl 7:68-77.
• 2012
  Hope WW, Castagnola E, Groll AH, Roilides E, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Cornely OA, Cuenca-Estrella M, Donnelly JP, Garbino J, Herbrecht R, Jensen HE, Kullberg BJ, Lass-Flörl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Verweij PE, Viscoli C, Ullmann AJ, , ESCMID* guideline for the diagnosis and management of Candida diseases 2012: prevention and management of invasive infections in neonates and children caused by Candida spp, Clin. Microbiol. Infect. 2012 Dec;18 Suppl 7:38-52.
• 2012
  Cornely OA, Bassetti M, Calandra T, Garbino J, Kullberg BJ, Lortholary O, Meersseman W, Akova M, Arendrup MC, Arikan-Akdagli S, Bille J, Castagnola E, Cuenca-Estrella M, Donnelly JP, Groll AH, Herbrecht R, Hope WW, Jensen HE, Lass-Flörl C, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Ullmann AJ, , ESCMID* guideline for the diagnosis and management of Candida diseases 2012: non-neutropenic adult patients, Clin. Microbiol. Infect. 2012 Dec;18 Suppl 7:19-37.
• 2012
  Cuenca-Estrella M, Verweij PE, Arendrup MC, Arikan-Akdagli S, Bille J, Donnelly JP, Jensen HE, Lass-Flörl C, Richardson MD, Akova M, Bassetti M, Calandra T, Castagnola E, Cornely OA, Garbino J, Groll AH, Herbrecht R, Hope WW, Kullberg BJ, Lortholary O, Meersseman W, Petrikkos G, Roilides E, Viscoli C, Ullmann AJ, , ESCMID* guideline for the diagnosis and management of Candida diseases 2012: diagnostic procedures, Clin. Microbiol. Infect. 2012 Dec;18 Suppl 7:9-18.
• 2012
  Ullmann AJ, Cornely OA, Donnelly JP, Akova M, Arendrup MC, Arikan-Akdagli S, Bassetti M, Bille J, Calandra T, Castagnola E, Garbino J, Groll AH, Herbrecht R, Hope WW, Jensen HE, Kullberg BJ, Lass-Flörl C, Lortholary O, Meersseman W, Petrikkos G, Richardson MD, Roilides E, Verweij PE, Viscoli C, Cuenca-Estrella M, , ESCMID* guideline for the diagnosis and management of Candida diseases 2012: developing European guidelines in clinical microbiology and infectious diseases, Clin. Microbiol. Infect. 2012 Dec;18 Suppl 7:1-8.
• 2012
  Parize P, Rammaert B, Lortholary O, Emerging invasive fungal diseases in transplantation, Curr Infect Dis Rep 2012 Dec;14(6):668-75.
• 2012
  Abravanel F, Raymond S, Pambrun E, Winnock M, Bonnard P, Sogni P, Trimoulet P, Dabis F, Salmon-Ceron D, Izopet J, , HIV-1 tropism and liver fibrosis in HIV-HCV co-infected patients, PLoS ONE 2012;7(11):e50289.
• 2012
  Joly V, Fagard C, Grondin C, Descamps D, Yazdanpanah Y, Charpentier C, Colin de Verdiere N, Tabuteau S, Raffi F, Cabie A, Chene G, Yeni P,, Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo), Antimicrob. Agents Chemother. 2013 Feb;57(2):758-65.
• 2012
  Charpentier C, Joly V, Larrouy L, Fagard C, Visseaux B, de Verdière NC, Raffi F, Yeni P, Descamps D,, Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial, J. Antimicrob. Chemother. 2013 Mar;68(3):690-6.
• 2012
  Desjardins A, Coignard-Biehler H, Mahlaoui N, Frange P, Bougnoux ME, Blanche S, Fischer A, Blumental S, Lortholary O, [Chronic granulomatous disease: pathogenesis and therapy of associated fungal infections], Med Sci (Paris) 2012 Nov;28(11):963-9.
• 2012
  Prinapori R, Guinaud J, Khalil A, Lecuyer H, Gendrel D, Lortholary O, Nassif X, Viscoli C, Zahar JR, Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae, Am J Infect Control 2013 Mar;41(3):259-60.
• 2012
  Loko MA, Bani-Sadr F, Valantin MA, Lascoux-Combe C, Fontaine H, Bonnard P, Gervais A, Bouchaud O, Garipuy D, Quertainmont Y, Vittecoq D, Tehrani MS, Winnock M, Dabis F, Salmon D, , Antiretroviral therapy and sustained virological response to HCV therapy are associated with slower liver fibrosis progression in HIV-HCV-coinfected patients: study from the ANRS CO 13 HEPAVIH cohort, Antivir. Ther. (Lond.) 2012;17(7):1335-43.
• 2012
  Ghosn J, Slama L, Chermak A, Houssaini A, Lambert-Niclot S, Schneider L, Fourn E, Duvivier C, Simon A, Courbon E, Murphy R, Flandre P, Peytavin G, Katlama C, , Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1, J. Med. Virol. 2013 Jan;85(1):8-15.
• 2012
  Carlet J, Rambaud C, Pulcini C, , [Alliance against MDRO: safeguarding antibiotics], Ann Fr Anesth Reanim 2012 Sep;31(9):704-8.
• 2012
  Troke P, Obenga G, Gaujoux T, Goldschmidt P, Bienvenu AL, Cornet M, Grenouillet F, Pons D, Ranque S, Sitbon K, Chaumeil C, Borderie V, Lortholary O, The efficacy of voriconazole in 24 ocular Fusarium infections, Infection 2013 Feb;41(1):15-20.
• 2012
  Planche V, Ducroz S, Alanio A, Bougnoux ME, Lortholary O, Dannaoui E, In vitro combination of anidulafungin and voriconazole against intrinsically azole-susceptible and -resistant Aspergillus spp, Antimicrob. Agents Chemother. 2012 Aug;56(8):4500-3.
• 2012
  Lefort A, Chartier L, Sendid B, Wolff M, Mainardi JL, Podglajen I, Desnos-Ollivier M, Fontanet A, Bretagne S, Lortholary O, , , Diagnosis, management and outcome of Candida endocarditis., Clin Microbiol Infect 2012 Apr; 18(4): E99-E109.
• 2012
  Rammaert B, Lanternier F, Poirée S, Kania R, Lortholary O, Diabetes and mucormycosis: a complex interplay, Diabetes Metab. 2012 Jun;38(3):193-204.
• 2012
  Rammaert B, Desjardins A, Lortholary O, New insights into hepatosplenic candidosis, a manifestation of chronic disseminated candidosis, Mycoses 2012 May;55(3):e74-84.
• 2010
  2. Join-Lambert O, Coignard H, Jais JP, Guet-Revillet H, Poirée S, Fraitag S, Jullien V, Ribadeau-Dumas F, Thèze J, Le Guern AS, Behillil S, Leflèche A, Berche P, Consigny PH, Lortholary O, Nassif X, Nassif, Efficacy of rifampin-moxifloxacin-metronidazole combination therapy in hidradenitis suppurativa. Dermatology, 2011;222(1):49-58. Epub 2010 Nov 25..
• 2010
  Lortholary O, Obenga G, Biswas P, Caillot D, Chachaty E, Bienvenu AL, Cornet M, Greene J, Herbrecht R, Lacroix C, Grenouillet F, Raad I, Sitbon K, Troke P,, International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole, Antimicrob. Agents Chemother. 2010 Oct;54(10):4446-50.